This inventor holds 1 USPTO granted patent. Top assignees: Sun Yat-Sen University Cancer Center, Sun Yat-Senuniversity. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 6 
1 out of 116 
Years Active: 2026
Title: Yulong Han: Inventor in Liver Cancer Research
Introduction
Yulong Han is an inventor associated with Guangzhou, China. His patent work focuses on a potential combination approach for treating hepatocellular carcinoma, a common form of liver cancer. He is associated with Sun Yat-Sen University and Sun Yat-Sen University Cancer Center.
Latest Patents
Han is named on 1 patent: “Use of BMP9 in Combination with NK Cell and PD-L1 Antibody in Preparing Medicament for Treating Liver Cancer.” The invention describes loading BMP9 onto drug-carrier microbubbles and using them alongside natural killer (NK) cells and a programmed death-ligand 1 (PD-L1) antibody. The patent reports that this combination significantly enhanced the efficacy of PD-L1 antibody therapy and inhibited the growth of hepatocellular carcinoma cell-graft tumors in the described research.
Career Highlights
Han’s listed institutional affiliations connect his work with Sun Yat-Sen University and its cancer center. His patent reflects research into combining a therapeutic protein, immune cells, and an immune checkpoint antibody as a potential cancer-treatment strategy.
Collaborations
Tong Xiang and Jianchuan Xia are identified as Han’s coworkers. Their names are associated with his professional and research network.
Conclusion
Yulong Han’s patent highlights an investigational combination of BMP9, NK cells, and PD-L1 antibody therapy for liver cancer, reflecting his connection to cancer research in Guangzhou.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile